Please use this identifier to cite or link to this item:
http://ri.uaemex.mx/handle20.500.11799/109383| Title: | Glycogen synthase kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NF-kB) in childhood acute lymphoblastic leukemia. | Keywords: | Glycogen Synthase Kinase-3β;Nuclear Factor Kappa-B;Childhood;Acute Lymphoblastic Leukemia;info:eu-repo/classification/cti/3 | Publisher: | Advances in Clinical and Experimental Medicine | Project: | 25 6 |
Description: | Background. Acute lymphocytic leukemia (ALL) is the most common hematologic malignancy in early childhood. In children with acute lymphoblastic leukemia (ALL), the activity of glycogen synthase kinase (GSK-3β) has been associated with changes in the transcriptional activity and expression of nuclear factor kappa beta (NFKB) in the mononuclear cells of bone marrow. Objectives. The aim of the study was to determine the possible role of glycogen synthase kinase 3beta (GSK-3β) and nuclear factor kappa beta (NFKB) as prognostic variables in pediatric patients with ALL. Material and Methods. This was a descriptive, transversal, and observational study. Bone marrow and blood samples were obtained from 30 children with newly-diagnosed ALL, who were seen at the Hematology-Oncology Service, Hospital para el Niño (HPN), Toluca, Mexico, from 2014‒2015. Anthropometric variables, clinical lab results, immunophenotype and cytogenetic abnormalities were registered. GSK-3β was evaluated through immunohistochemistry, and NFKB messenger RNA (mRNA) with real-time polymerase chain reaction (qPCR). The cases of ALL were classified into two groups of risk: high and habitual. Results. Thirty patients were included in this study, with a mean age of 7.1 years (range 2‒13 years). Twenty-one were male and 9 female. Employing the morphological classification, 26 patients had type L1 ALL and the remaining 4 patients had type L2 ALL. Abnormal genes were found in 7 (23.33%) patients, ETV-RUNX1 in 3, followed by TCF3-PBX1 (two), STL1-TAL1 (one), and BCR-ABL1 (one). NFKB relative expression levels, in comparison to the GSK-3β immunohistochemistry results of the bone marrow samples, showed significant differences between positive and negative cases (p = 0.001) and between weak-positive and negative cases (p = 0.002). Conclusions. These results suggest that GSK-3β may be a prognostic biomarker in childhood ALL Ciprés Grupo Médico |
URI: | http://ri.uaemex.mx/handle20.500.11799/109383 | Other Identifiers: | http://hdl.handle.net/20.500.11799/109383 | Rights: | info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-nd/4.0 |
| Appears in Collections: | Producción |
Show full item record
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.